West Nile Virus (WNV) is an encapsulated flavivirus that is spread from infected birds to humans by mosquito bites. It can also be transmitted by receipt of blood transfusions and organ transplants. It was introduced into the United States in 1999.…
A critical element of clinical research is the relationship between the trial participant and the Principal Investigator (PI). Subjects involved in clinical research programs are dependent on the PI for guidance and education as well as for their…
Whereas the Office of Cellular and Gene Therapies (OCGT) of the FDA is responsible for regulatory oversight of therapies which may cure bleeding disorders;
Whereas the OCGT, a part of the Center for Biologics Evaluation and Review (CBER), has…
It is well documented that persons with congenital hemophilia and acquired hemophilia require treatment with clotting factor concentrates not only for treatment of bleeding episodes but also to prevent bleeding when admitted to the hospital for…
MASAC recognizes that there is a dearth of new physicians exiting training programs with clinical and research competency in hemostasis and thrombosis. To address this critical manpower shortage, MASAC proposes that NHF evaluate the use of…
Revisions: 149.Whereas, the World Health Organization Essential Medicine List (WHO-EML) presents the minimum medication needs for a basic health care system. The most efficacious, safe and cost-effective medicines for priority conditions are…
Parvovirus B19 infection during pregnancy may cause fetal anemia, hydrops fetalis, and fetal demise. Infection during the third trimester can induce severe congenital hypoplastic anemia in the infant. Parvovirus B19 may be transmitted by blood…
Funding for hemophilia clinics continues to be flat, and the ability to maintain set-aside services for hemophilia continues to dwindle. In addition, the supply of informed, trained health care providers continues to decrease, and efforts to recruit…
There are now available several different recombinant factor products for the treatment of hemophilia. There are specific considerations in prescribing a product for any individual patient.
Therefore MASAC recommends that insurance companies and…
Much has changed since the previous MASAC Recommendation #124. Although the changes are summarized briefly below, MASAC strongly recommends that providers refer to the source document referenced below, entitled "Guidelines for the Use of…